WASHINGTON, D.C. – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, and Congressman Dan Crenshaw (TX-02), issued a statement following House passage of H.R. 498, the Do No Harm in Medicaid Act—legislation that prohibits federal Medicaid dollars from going toward specified gender transition procedures for individuals under the age of 18.

“The Do No Harm in Medicaid Act helps strengthen, sustain, and secure our Medicaid program by ensuring federal Medicaid funding is not used for medically unnecessary care for minors,” said Chairman Guthrie. “I’m thankful to my colleague, Representative Dan Crenshaw, for his diligent work in protecting our nation’s children. It’s our duty as members of Congress to support our fellow Americans—especially our most vulnerable—by prohibiting valuable and finite taxpayer dollars from continuing to fund controversial, life-altering gender transition procedures for individuals under the age of 18.”

“Using Medicaid for unscientific, irreversible procedures on minors is an abominable betrayal of our most vulnerable,” said Rep. Crenshaw. “This is a crucial step in protecting our children from the depraved actors that would do them harm.”

Background on H.R. 498:

• H.R. 498, the Do No Harm in Medicaid Act, prohibits federal Medicaid funding for specified gender transition procedures for individuals under the age of 18.
• The House also passed this bill as a provision within H.R. 1, the budget reconciliation bill, on May 22, 2025.
• The Congressional Budget Office estimates that H.R. 498 would reduce direct spending for Medicaid and CHIP by $445 million over the 2026-2035 period.
• Publicly available polling has consistently indicated that Americans oppose providing children with puberty blockers and irreversible surgeries.
• The U.S. Department of Health and Human Services (HHS) announced today a series of proposed regulatory actions to carry out President Trump’s Executive Order directing HHS to end the practice of sex-rejecting procedures on children that expose young people to irreversible harm, including pharmaceutical or surgical interventions that attempt to align a child’s physical appearance or body with an asserted identity different from their sex.

###